IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
ANG Lifesciences India IPO is a Fixed Price IPO listing on BSE SME exchange, with an ipo size of ₹ 12.01 Cr. The company is based in Amritsar and caters to Pharmaceutical sector. Guiness Corporate Advisors is the merchant banker of ANG Lifesciences India IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th August 2017.
ANG Lifesciences India IPO open date is 29th August 2017 and close date is 31st August 2017. IPO Allotment Date is 30th November -0001 and Listing date is 8th September 2017.
IPO
Size:
₹ 12.01 Cr.
Avg IPO Size (Sector Based)
: ₹
21.99 cr.
Sector: Pharmaceutical
SME
IPO so far:
40
Merchant Banker:
Guiness Corporate
SME
IPO by BRLM so far:
47
City:
Amritsar
SME
IPO so far:
3
Revenue (annualised):
₹
67.92
cr. 
PE
Ratio:
14.00x
Average Sector PE Ratio: 20.74x
ANG Lifesciences India IPO size is ₹ 12.01 Cr. with IPO price of ₹ 80.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Guiness Corporate Advisors Private Limited is the book-running lead manager of the ANG Lifesciences India IPO. Bigshare Services Private Limited is the Registrar and Market Maker is Guiness Securities Limited for ANG Lifesciences India IPO.
ANG Lifesciences India IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
ANG Lifesciences India IPO, based in Amritsar, operates in the Pharmaceutical sector with a focus on manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials.. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. ANG Lifesciences India IPO size is ₹ 12.01 Cr. with fresh issue size of ₹ 12 and Offer for sale being ₹ Nil
The IPO allotment date for ANG Lifesciences India IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check ANG Lifesciences India IPO allotment status on the registrars website, Bigshare Services Private Limited . ANG Lifesciences India IPO refund dates are 30th November -0001.
ANG Lifesciences India IPO is expected to be listed on 8th September 2017.
The upper price band for the ANG Lifesciences India IPO is set at ₹ 80.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on ANG Lifesciences India IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the ANG Lifesciences India IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 31st August 2017. After submission, funds are blocked until the basis of allotment of ANG Lifesciences India IPO is finalised.
The merchant banker for ANG Lifesciences India IPO is Guiness Corporate Advisors Private Limited . Guiness Corporate Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the ANG Lifesciences India IPO RHP for further details.
The registrar for ANG Lifesciences India IPO is Bigshare Services Private Limited . Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to ANG Lifesciences India IPO through their official website or helpline.
ANG Lifesciences India IPO was subscribed 0.00 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 12.01 Cr.
Avg IPO Size (Sector Based)
:
₹ 21.99 Cr.
Sector: Pharmaceutical
SME
IPO so far:
40
Merchant Banker:
Guiness Corporate
SME
IPO by BRLM so far:
47
City:
Amritsar
SME
IPO so far:
3
Revenue (annualised):
₹ 67.66 cr.
PE
Ratio:
14.00x
Average Sector PE Ratio: 20.74x
ANG Lifesciences India IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on ANG Lifesciences India Financial Review Page
Merchant Banker(s) of ANG Lifesciences India IPO: Guiness Corporate Advisors Private Limited
ANG Lifesciences India IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
ANG Lifesciences India IPO listed at a listing price of 96.00 against the offer price of 80.00.
The current market price of ANG Lifesciences India is 31.13.
Why Us?
